191
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Mesenchymal Stem Cell Transplantation: Neuroprotection and Nerve Regeneration After Spinal Cord Injury

ORCID Icon, , , , , , , , & show all
Pages 4763-4776 | Received 01 Jul 2023, Accepted 03 Oct 2023, Published online: 20 Oct 2023
 

Abstract

Spinal Cord Injury (SCI), with its morbidity characteristics of high disability rate and high mortality rate, is a disease that is highly destructive to both the physiology and psychology of the patient, and for which there is still a lack of effective treatment. Following spinal cord injury, a cascade of secondary injury reactions known as ischemia, peripheral inflammatory cell infiltration, oxidative stress, etc. create a microenvironment that is unfavorable to neural recovery and ultimately results in apoptosis and necrosis of neurons and glial cells. Mesenchymal stem cell (MSC) transplantation has emerged as a more promising therapeutic options in recent years. MSC can promote spinal cord injury repair through a variety of mechanisms, including immunomodulation, neuroprotection, and nerve regeneration, giving patients with spinal cord injury hope. In this paper, it is discussed the neuroprotection and nerve regeneration components of MSCs’ therapeutic method for treating spinal cord injuries.

Acknowledgments

Si-Yu Chen: Writing - Original Draft. Rui-Lin Yang, Xiang-Chong Wu, De-Zhi Zhao, Sheng-Ping Fu, Feng-Qin Lin, Lin-Yan Li, Li-Mei Yu and Qian Zhang: Writing - Review & Editing. Tao Zhang: Writing - Review & Editing, Funding acquisition.

Disclosure

The authors declare that there is no conflict of interest regarding the publication of this paper.

Additional information

Funding

This work was supported by grants from the National Natural Science Foundation of China (No.81960299).